Aurora Cannabis Inc. (NASDAQ:ACB – Free Report) – Equities research analysts at Roth Capital issued their Q1 2026 earnings per share (EPS) estimates for shares of Aurora Cannabis in a note issued to investors on Thursday, February 6th. Roth Capital analyst W. Kirk anticipates that the company will post earnings per share of $0.17 for the quarter. The consensus estimate for Aurora Cannabis’ current full-year earnings is ($0.10) per share. Roth Capital also issued estimates for Aurora Cannabis’ Q2 2026 earnings at $0.02 EPS, Q3 2026 earnings at $0.40 EPS and Q4 2026 earnings at $0.29 EPS.
A number of other brokerages also recently weighed in on ACB. TD Cowen assumed coverage on shares of Aurora Cannabis in a research note on Wednesday, December 11th. They set a “buy” rating for the company. TD Securities upgraded shares of Aurora Cannabis to a “strong-buy” rating in a research note on Thursday, December 12th.
Aurora Cannabis Stock Up 16.4 %
Shares of NASDAQ ACB opened at $6.25 on Friday. The company’s 50 day moving average price is $4.24 and its 200-day moving average price is $5.16. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.88 and a current ratio of 3.83. Aurora Cannabis has a 52-week low of $2.84 and a 52-week high of $9.35. The company has a market capitalization of $342.86 million, a P/E ratio of -8.22 and a beta of 1.84.
Aurora Cannabis (NASDAQ:ACB – Get Free Report) last posted its quarterly earnings data on Wednesday, February 5th. The company reported $0.06 EPS for the quarter, topping analysts’ consensus estimates of ($0.09) by $0.15. Aurora Cannabis had a negative return on equity of 2.19% and a negative net margin of 17.47%.
Hedge Funds Weigh In On Aurora Cannabis
A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Wealthspire Advisors LLC bought a new position in shares of Aurora Cannabis in the fourth quarter valued at $149,000. Tidal Investments LLC lifted its position in Aurora Cannabis by 2.7% in the 3rd quarter. Tidal Investments LLC now owns 1,344,321 shares of the company’s stock valued at $7,905,000 after acquiring an additional 34,988 shares in the last quarter. Cubist Systematic Strategies LLC acquired a new position in Aurora Cannabis during the 2nd quarter valued at about $50,000. Finally, SBI Securities Co. Ltd. bought a new stake in Aurora Cannabis during the 4th quarter worth approximately $31,000. Institutional investors own 47.63% of the company’s stock.
About Aurora Cannabis
Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Featured Articles
- Five stocks we like better than Aurora Cannabis
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Price Plunge in Roblox Presents Opportunity for Robust Gains
- How is Compound Interest Calculated?
- Billions in Buybacks: 4 Stocks Rewarding Shareholders Now
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- 3 Steel Stocks to Gain Strength as Tariffs Reshape the Market
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.